1. Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways
   Xiangning Bu et al, 2019, Biochemical Pharmacology CrossRef
2. Effects of β-caryophyllene on arginine ADP-ribosyltransferase 1-mediated regulation of glycolysis in colorectal cancer under high-glucose conditions
   Li Zhou et al, 2018, International Journal of Oncology CrossRef
3. Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non–small cell lung cancer
   Erik Wennerberg et al, 2022, Science Translational Medicine CrossRef
4. Identification of the role of mono-ADP-ribosylation in colorectal cancer by integrated transcriptome analysis
   Shuxian Zhang et al, 2021, Medical Oncology CrossRef
5. Arginine ADP-ribosyltransferase 1 Regulates Glycolysis in Colorectal Cancer via the PI3K/AKT/HIF1α Pathway
   Wen-bo Long et al, 2022, Current Medical Science CrossRef
6. Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight
   Ann-Katrin Hopp et al, 2021, Cells CrossRef
7. Promising anticancer activity of cromolyn in colon cancer: in vitro and in vivo analysis
   Amin Aliabadi et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef
8. FOS licenses early events in stem cell activation driving skeletal muscle regeneration
   Albert E. Almada et al, 2021, Cell Reports CrossRef
9. Hyperresponsiveness to interferon gamma exposure as a response mechanism to anti-PD-1 therapy in microsatellite instability colorectal cancer
   Wenli Yuan et al, 2019, Cancer Immunology, Immunotherapy CrossRef
10. In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning
    Amin Aliabadi et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
11. ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer cells
    Ting Lin et al, 2024, BMC Cancer CrossRef